![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 17, 2017 5:15:07 PM
Following South Africa's Governmental approval for the sale of cannabis medicines in that country in February 2017, the company was advised by the Deputy-Director of Health in April 2017 that the government had approved the application for the issuance of a Cannabis research and development license subject to inspection of the company’s South Africa research and development facilities, expected in May 2017. This license would allow the growing, harvesting, processing and the recovery of a Phytofare® cannabinoid complex; extending to analysis, product profiling and clinical investigation, followed by commercialization.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM